The Lung Cancer Sessions: Highlights from ASCO 2021

Following the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting, VJOncology brought together a group of leading lung cancer experts to offer their perspectives on the latest research advances presented at the meeting and how they could impact lung cancer care in the future.

In this exclusive post-ASCO podcast, Melissa Johnson, MD, Sarah Cannon Research Institute, Nashville, TN, is joined by Lizza Hendriks, MD, PhD, Maastricht University, Maastricht, Netherlands, and Heather Wakelee, MD, Stanford University, Stanford, CA, as they delve into the latest practice-changing lung cancer data.

Listen to this esteemed panel discuss adjuvant trials including IMpower010, CTONG1103 and  IMPACT, as well as biomarkers of response. The panel also cover targeted therapies including KRAS inhibitors such as sotorasib, HER3-directed antibody-drug-conjugates, as well as the treatment of lung cancer with EGFR exon 20 insertions.

The post The Lung Cancer Sessions: Highlights from ASCO 2021 appeared first on VJOncology.